
==== Front
Sao Paulo Med J
Sao Paulo Med J
Sao Paulo Med J
São Paulo Medical Journal
1516-3180
1806-9460
Associação Paulista de Medicina - APM

20512287
10.1590/S1516-31802009000600004
Original Article
Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values
Frequência de lesões endometrióticas em amostras de peritônio de mulheres férteis assintomáticas e correlação com valores de CA125Barbosa Caio Parente
de Souza Ângela Mara Bentes
Bianco Bianca
Christofolini Denise
Bach Fernanda Abani Mafra
de Lima Geraldo Rodrigues
I MD, PhD. Regent professor, Division of Pathological Gynecology, Department of Gynecology and Obstetrics, Faculdade de Medicina do ABC, Santo André, São Paulo; and Gynecologist, Division of Gynecology, Department of Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil
II MD, PhD. Associate professor, Division of Pathological Gynecology, Department of Gynecology and Obstetrics, Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil.
III PhD. Geneticist and collaborating professor, Division of Pathological Gynecology, Department of Gynecology and Obstetrics, Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil.
IV Postgraduate student, Division of Pathological Gynecology, Department of Gynecology and Obstetrics, Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil.
V MD, PhD. Titular professor, Division of Gynecology, Department of Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.
Address for correspondence: Caio Parente Barbosa. Faculdade de Medicina do ABC (FMABC), Disciplina de Genética e Reprodução Humana. Av. Príncipe de Gales, 821, Santo André (SP) - Brasil. CEP 09060-650. Tel. (+55 11) 4438-7299. Fax. (+55 11) 4438-7299. E-mail:caiopb@uol.com.br
Conflict of interest: Not declared

21 5 2010
2009
127 6 342345
21 1 2009
25 8 2009
27 11 2009
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons license.
ABSTRACT

CONTEXT AND OBJECTIVE:

Serological testing for CA125 has been widely used to detect endometriosis and to monitor its progression. However, controversy still exists regarding the usefulness of the plasma CA125 assay for diagnosing endometriosis. Furthermore, some authors have described superficial endometriosis as a cyclical and normal phenomenon in women’s lives, and have indicated that development and progression of this disease would only occur in some women as a result of immunological changes. This study aimed to determine the frequency of endometriosis and the correlation between serum CA125 levels and the presence of endometriotic lesions in the peritoneum of asymptomatic fertile patients.

DESIGN AND SETTING:

Cross-sectional study at the Family Planning outpatient clinic of Faculdade de Medicina do ABC.

METHODS:

Eighty asymptomatic fertile patients who underwent tubal sterilization surgery were studied. Blood and peritoneum samples were collected. CA125 levels were measured from blood samples, and peritoneum biopsies were studied using histopathological tests.

RESULTS:

Histopathological evaluation of the peritoneum revealed that 16.25% of the patients had minimal or mild endometriosis. There was no statistically significant difference in CA125 levels between patients with and without endometriosis.

CONCLUSION:

The presence of endometriotic lesions in the peritoneum of fertile patients supports the hypothesis that incidental findings of minimal or mild endometriosis may not be of clinical significance, and that the progression of the disease probably occurs as a result of immunological and genetic abnormalities. Serum CA125 levels did not show any diagnostic significance with regard to detecting the disease.

RESUMO

CONTEXTO E OBJETIVO:

O teste sorológico para CA125 tem sido largamente usado para detectar e monitorar a progressão da endometriose, entretanto, a utilidade do ensaio do CA125 plasmático para o diagnóstico da endometriose ainda é controversa. Além disso, alguns autores descreveram a endometriose superficial como sendo um fenômeno cíclico e normal na vida de uma mulher, e que o desenvolvimento e progressão desta doença ocorreriam apenas em algumas mulheres como resultado de alterações imunológicas. Este estudo teve como objetivo determinar a freqüência de endometriose e a correlação entre os níveis séricos de CA125 e a presença de lesões endometrióticas em peritônio de pacientes férteis assintomáticas.

TIPO DE ESTUDO E LOCAL:

Estudo transversal realizado no Ambulatório de Planejamento Familiar da Faculdade de Medicina do ABC.

MÉTODOS:

Foram estudadas 80 pacientes férteis assintomáticas submetidas à cirurgia de esterilização tubária. Amostras de sangue e peritônio foram coletadas. Os níveis de CA125 foram medidos a partir das amostras de sangue e as biópsias de peritônio foram estudadas por ensaio histopatológico.

RESULTADOS:

O estudo histopatológico do peritônio revelou que 16,25% das pacientes apresentavam endometriose mínima e leve. Os níveis de CA125 não demonstraram diferença estatística significante entre pacientes com e sem endometriose.

CONCLUSÃO:

A presença de lesões endometrióticas em peritônio de pacientes férteis reforça a hipótese de que achados acidentais de endometriose mínima e leve podem não ter significância clínica, e que é provável que a progressão da doença ocorra como resultado de alterações genéticas e imunológicas. Os níveis séricos de CA125 não demonstraram significância diagnóstica para a detecção da doença.

KEY WORDS:

Endometriosis
Pelvic pain
Infertility
Dysmenorrhea
CA-125 antigen
PALAVRAS-CHAVE:

Endometriose
Dor pélvica
Infertilidade
Dismenorréia
Antígeno Ca-125
==== Body
pmcINTRODUCTION

An endometriotic lesion is defined as the presence of endometrial tissue outside the uterus, thus causing infertility, pelvic pain and dysmenorrhea.1 Estimates of the frequency of endometriosis range from 10-15% in women of reproductive age2 up to 50% in women with fertility problems1 and around 60%-70% in women with chronic pelvic pain.3 However, up to 20% of women may have endometriosis without presenting any symptoms.1

In clinical practice, severe endometriosis can be diagnosed with high accuracy by means of pelvic examination and through using imaging tools such as transvaginal ultrasonography4 and magnetic resonance.5 However, these methods are not sensitive enough to detect mild endometriosis,6 and laparoscopy or laparotomy is necessary in order to confirm the diagnosis and classify the stage of endometriosis according to the criteria of the American Fertility Society.7

Some authors have described superficial endometriosis as a cyclical and normal phenomenon in women’s lives, and have indicated that development and progression of this disease would only occur in some women as a result of immunological changes.8,9 Thus, the low specificity of the diagnostic methods available, along with the severity of the disease, has motivated new studies to search for noninvasive diagnostic methods to detection endometriosis.6

Serological testing for CA125 has been widely used to detect endometriosis and to monitor its progression.10 However, controversy still exists regarding the usefulness of the plasma CA125 assay for diagnosing endometriosis.11,12 Moreover, only a small and limited number of studies in the literature have combined peritoneal and serum samples,3 especially among asymptomatic fertile women.

OBJECTIVE

This study aimed to determine the frequency of endometriosis and the correlation between serum CA125 levels and the presence of endometriotic lesions in the peritoneum of asymptomatic fertile patients.

MATERIAL AND METHODS

Patients

Eighty fertile women with no symptoms of endometriosis such as infertility, pelvic pain and/or dysmenorrhea (aged 21-44 years, mean: 33.68 ± 4.63) were studied. All of the subjects were attending the Family Planning outpatient clinic of Faculdade de Medicina do ABC (FMABC), Santo André, Brazil, and underwent surgery for tubal sterilization as a familiar planning measure.

The study protocol was approved by the local research ethics committee. All patients gave their informed consent for inclusion in the study.

METHODS

Histopathological evaluation

The patients underwent laparoscopic surgery for tubal sterilization and, during the procedure, small pieces of peritoneum were excised from four different sites: left and right ovarian fossae, and left and right sacrouterine ligaments.

The biopsy specimens were fixed in a 10% formalin solution and embedded in paraffin. Histological sections (3-5 mm thick) were cut and stained with hematoxylin-eosin. A total of 320 microscope slides stained with hematoxylin-eosin were studied (Figure 1).

The criterion for histological classification of endometriosis was identification of stromal endometrioid or epithelial elements of Müllerian type, with or without stroma, associated with signs of hemorrhage and fibrosis.

After histological confirmation of the diagnosis of endometriosis, the lesions were classified morphologically, based on the variations in appearance of the ectopic endometrial structures.13 The morphological criteria for the analysis were: stromal disease, when only endometrial stroma was found; well-differentiated disease, when glands similar to topical endometrium were found; undifferentiated disease, when the appearance of the glands was different from topical endometrium; and mixed disease, when the appearance of the glands was atypical or undifferentiated.14 Endometriosis was staged according to the revised American Fertility Society (r-AFS) classification.15

Figure 1. Photomicrographs at 100 X (A) and 400 X (B and C) of histological findings from peritoneum of asymptomatic fertile patients showing endometriosis (A and B), compared with normal tissue (C) (hematoxylin-eosin staining).

Serum CA125 level

Blood samples were collected on the first three days of the cycle prior to surgery. After collection, the blood samples were immediately centrifuged; the serum was removed, placed in a cryotube and frozen at -80 °C. Serum CA125 levels were measured in accordance with the manufacturer’s instructions (BYK-Sangtec Diagnostica GmbH, Germany). When the CA125 values were higher than 35 U/ml, a second measurement was performed to confirm the result.

Statistical analysis

The Mann-Whitney test was performed to compare the serum CA125 levels among the patients. The significance level was set at 5% (a £ 0.05).

RESULTS

The histopathological evaluation revealed that 13 (16.25%) out of these 80 patients (without any symptoms of endometriosis like infertility, dysmenorrhea and/or pelvic pain) showed level I or II endometriotic lesions. Of these patients, six (7.5%) had typical and four (5.0%) had atypical lesions. In three patients (3.8%), lesions were found only in the histopathological evaluation study (unapparent endometriosis). In six of these cases, the endometriosis was located in sacrouterine ligaments, and in five in ovarian fossae. In two cases, we found lesions at more than one site. No ovarian endometriosis was observed.

No statistical difference in serum CA125 levels was observed between patients with and without endometriosis: means of 26.9 and 28.3 U/ml, respectively (P = 0.6389 and sample power of 67%).

DISCUSSION

Endometriosis, a chronic painful inflammatory disease that is one of the most common gynecological disorders,7 is defined as the presence of a steroid hormone-dependent endometrium-like tissue consisting of glands and stroma that grows outside the uterine cavity. The target tissues and organs include the fallopian tubes, ovaries, peritoneum, colon, rectovaginal region and bladder.16 Endometriosis causes infertility, pelvic pain and dysmenorrhea.1,17 However, up to 20% of women may have endometriosis without presenting any symptoms.7 It is a polygenic/multifactorial disease that includes not only hormonal and immunological factors, but also genetic factors.17

Considerable efforts have been made towards searching for noninvasive diagnostic methods to detect endometriosis. Moreover, the use of biomarkers has been widely discussed. Abrão et al.8 evaluated serum CA125, C-reactive protein, amyloid A protein and anticardiolipin antibodies during the menstrual phase and the middle follicular phase. They found that CA125 was the marker presenting the highest levels during the menstrual phase, between the first and third days of the cycle.

The high levels of CA125 in the bloodstream observed in the presence of an endometriotic ovarian cyst and/or endometriosis with deep infiltration suggest that this antigen may pass into the circulation from endometrial cells in patients with endometriosis.18,19 The CA125 released by the endometrium may reach the blood stream and lymphatic circulation via the peritoneal route, starting from retrograde menstruation, thereby allowing contact with local inflammatory reactions and thus releasing coelomic CA125.20 Another explanation for the increased levels of CA125 in the bloodstream could be its access into the abdominal cavity through tubal reflux, thus resulting in absorption by peritoneal lymphatic vessels. Despite the mechanisms proposed, doubts still persist about the real mechanism of CA125 release into the circulation, considering that retrograde menstruation is still controversial and that the levels of this marker change during the postmenopausal period.20 Koninckx and Martin21 evaluated CA125 and concluded that superficial endometriosis causes elevation of CA125 levels in peritoneal fluid, whereas the deep disease causes their elevation in blood.

Several hypotheses have been raised to explain the cause of elevated serum CA125 at the time of menstruation in patients with endometriosis. They include higher membrane CA125 concentration in ectopic cells than in eutopic endometrial cells;22 bleeding relating to eutopic endometrium;23 increased transition of CA125 from endometrial tissue to peritoneum, relating to retrograde menses and eutopic endometrium;22,23 an enlarged surface area of endometrial tissue;24 inflammatory reaction due to the presence of endometriotic foci; and blood and endometrial shedding into the peritoneal cavity.23,24

Many studies have reported that serum CA125 levels were higher in patients with endometriosis, especially in those at an advanced level, suggesting that monitoring of CA125 in peripheral blood might reflect its behavior in the abdominal environment.3,25

On the other hand, some authors consider superficial endometriosis to be a physiological and intermittent condition in women during their reproductive years, whereas its progression, characterized as deep infiltrative endometriosis and/or endometrial ovarian cysts, is considered to be the true disease.9,13,19,26 Divergences persist regarding the natural history of endometriosis, its symptoms, extent, location and staging. The presence of pelvic pain, especially dysmenorrhea, plus infertility and dyspareunia, are the trio that characterizes the disease.9

In the present study, 16.25% of the patients had mild endometriosis, and the serum CA125 levels showed no difference between fertile asymptomatic women with and without endometriosis, although the number of cases investigated was small. Moreover, endometriosis was observed in healthy peritoneum of fertile women,27 in the same way as reported by Nezhat et al.,28 Nisolle et al.29 and Balasch et al.30 among women with infertility and pelvic pain.

CONCLUSION

In conclusion, the data suggest that incidental findings of minimal/mild endometriosis may not be of clinical significance, and progression of the disease probably occurs as a result of immunological and genetic abnormalities.The serum CA125 levels in our study did not show any diagnostic significance for detecting the disease.

Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil

Sources of funding: Not declared
==== Refs
REFERENCES

1 Missmer SA Cramer DW The epidemiology of endometriosis Obstet Gynecol Clin North Am 2003 30 1 1 19 vii 12699255
2 Mahmood TA Templeton A Prevalence and genesis of endometriosis Hum Reprod 1991 6 4 544 549 1918305
3 Amaral VF Ferriani RA Sá MF Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis Sao Paulo Med J 2006 124 4 223 227 17086305
4 Dessole S Farina M Rubattu G Cosmi E Ambrosini G Nardelli GB Sonovaginography is a new technique for assessing rectovaginal endometriosis Fertil Steril 2003 79 4 1023 1027 12749448
5 Stratton P Winkel C Premkumar A Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis Fertil Steril 2003 79 5 1078 1085 12738499
6 Kitawaki J Ishihara H Koshiba H Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas Hum Reprod 2005 20 7 1999 2003 15890727
7 Renner SP Strick R Oppelt P Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis Reproduction 2006 131 1 153 161 16388018
8 Abrão MS Podgaec S Filho BM Ramos LO Pinotti JA de Oliveira RM The use of biochemical markers in the diagnosis of pelvic endometriosis Hum Reprod 1997 12 11 2523 2527 9436699
9 Vercellini P Trespidi L Panazza S Bramante T Mauro F Crosignani PG Laparoscopic uterine biopsy for diagnosing diffuse adenomyosis J Reprod Med 1996 41 4 220 224 8728071
10 Cheng YM Wang ST Chou CY Serum CA-125 in preoperative patients at high risk for endometriosis Obstet Gynecol 2002 99 3 375 380 11864662
11 Harada T Kubota T Aso T Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis Fertil Steril 2002 78 4 733 739 12372448
12 Somigliana E Viganò P Tirelli AS Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions Hum Reprod 2004 19 8 1871 1876 15218003
13 Hoeger KM Guzick DS An update on the classification of endometriosis Clin Obstet Gynecol 1999 42 3 611 619 10451773
14 Abrao MS Neme RM Carvalho FM Aldrighi JM Pinotti JA Histological classification of endometriosis as a predictor of response to treatment Int J Gynaecol Obstet 2003 82 1 31 40 12834939
15 Revised American Society for Reproductive Medicine classification of endometriosis: 1996 Fertil Steril 1997 67 5 817 821 9130884
16 Giudice LC Kao LC Endometriosis Lancet 2004 364 9447 1789 1799 15541453
17 Bulun SE Zeitoun KM Takayama K Sasano H Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance J Mol Endocrinol 2000 25 1 35 42 10915216
18 Pittaway DE Rondinone D Miller KA Barnes K Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis Fertil Steril 1995 64 2 321 324 7615110
19 Koninckx PR Is mild endometriosis a condition occurring intermittently in all women? Hum Reprod 1994 9 12 2202 2205 7714127
20 Bon GG Kenemans P Dekker JJ Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles Hum Reprod 1999 14 2 566 570 10100011
21 Koninckx PR Martin DC Deep endometriosis: a consequence of infiltration or retraction or possibly adenomyosis externa? Fertil Steril 1992 58 5 924 928 1426377
22 Niloff JM Knapp RC Jones G Schaetzl EM Bast RC Jr Recombinant leukocyte alpha interferon in advanced ovarian carcinoma Cancer Treat Rep 1985 69 7-8 895 896 4016797
23 Falconer H Bambra CS Chai D Cornillie FJ Hill JA D’Hooghe TM The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons Hum Reprod 2005 20 11 3033 3038 16037112
24 Johansson J Santala M Kauppila A Explosive rise of serum CA 125 following the rupture of ovarian endometrioma Hum Reprod 1998 13 12 3503 3504 9886540
25 Koninckx PR Meuleman C Oosterlynck D Cornillie FJ Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration Fertil Steril 1996 65 2 280 287 8566249
26 Nisolle M Nervo P Endométriose stade I et II: implications physiopathologiques, cliniques et thérapeutiques [Physiopathology and therapeutic management of stage I and II endometriosis] J Gynecol Obstet Biol Reprod Paris 2003 32 8 Pt 2 S11 S14
27 Barbosa CP de Souza AM Bianco B Christofolini DM Mafra FA de Lima GR OC-125 immunostaining in endometriotic lesion samples Arch Gynecol Obstet 2009 [Epub ahead of print]
28 Nezhat F Allan CJ Nezhat C Martin DC Nonvisualized endometriosis at laparoscopy Int J Fertil 1991 36 6 340 343 1684957
29 Nisolle M Casanas-Roux F Anaf V Mine JM Donnez J Morphometric study of the stromal vascularization in peritoneal endometriosis Fertil Steril 1993 59 3 681 684 8458479
30 Balasch J Creus M Fábregues F Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study Hum Reprod 1996 11 2 387 391 8671229
